The “Big Five” Canadian banks offer investment funds and include Royal Bank of Canada, Toronto Dominion Bank (TD Canada Trust), Bank of Nova Scotia, Bank of Montreal and Canadian Imperial Bank of Commerce (CIBC). Let’s explore the best place for you to invest.
Latest News
Making sense of the markets this week: December 7 + MORE Dec 4th
Each week, Cut the Crap Investing founder Dale Roberts shares financial headlines and offers context for Canadian investors.
Canadians with smaller portfolios are the target for deferred service charge (DSC) mutual funds
There was some good news and bad news in this article on Advisor’s Edge. Th.... More »
Stock news for investors: Barrick leads earnings gains as major Canadian companies report mixed Q3 results + MORE Nov 13th
Here’s a round-up of news for Canadian investors this week.
Barrick
MEG Energy
Loblaw
Manulife
Linamar
Brookfield
Hydro One
Featured RRSP Accounts
featured
EQ Bank
.... More »
Find the best mortgage rates in Canada Feb 4th
Mortgage rate comparison tool
Shopping around for the best rate can save you thousands on your mortgage. To instantly compare rate types and terms, click on the filters icon beside the down payment percentage in the Ratehub mortgage rate finder below. Input your location, the price of the home yo.... More »
Floor collapses at stock exchange in Indonesia, injuring dozens - The Guardian + MORE Jan 15th
The GuardianFloor collapses at stock exchange in Indonesia, injuring dozensThe GuardianA floor at Indonesia's stock exchange has collapsed into the building's lobby, injuring at least 50 people. Part of the floor on the first level gave way, sending debris crashing on to the ground level, .... More »
Scotiabank credit cards: A breakdown of the bank’s best cards + MORE Nov 25th
Scotiabank (originally called the Bank of Nova Scotia) is technically older than Canada itself. Founded in Halifax in 1832, the bank beat Confederation by 35 years. With that amount of history in the business, it’s no surprise the bank can offer and support a wide variety of products—including 1.... More »
Valeant stock plunges on TSX after news of CEO’s medical leave
– theglobeandmail.com
The drug maker announced Monday that Michael Pearson in taking a leave while being treated for pneumonia
Canadian Oil Sands tells shareholders to reject Suncor bid as deadline looms
– canadianbusiness.com
CALGARY – Canadian Oil Sands is again urging its shareholders to reject a takeover bid by Suncor Energy, which has set Jan. 8 as the deadline for investors.
The company (TSX:COS) sent a letter to its shareholders Tuesday in the latest back-and-forth between the two Calgary-based firms, saying it can weather prolonged low oil prices on its own and thrive once crude recovers.
The missive, a response to Suncor’s renewed appeal earlier this month to accept the deal, says it’s not the right time to sell Canadian Oil Sands given the low price of crude and oil stocks.
Suncor has argued that with oil prices expected to remain low for some time, the status quo is risky for COS shareholders.
Based on Suncor’s most recent closing stock price Thursday, the all-stock bid is worth about $4.5 billion.
Suncor (TSX:SU) took its offer directly to COS shareholders on Oct. 5 after attempts to ink a friendly deal — at a higher price — were rebuffed by Canadian Oil Sands in the spring…
The company (TSX:COS) sent a letter to its shareholders Tuesday in the latest back-and-forth between the two Calgary-based firms, saying it can weather prolonged low oil prices on its own and thrive once crude recovers.
The missive, a response to Suncor’s renewed appeal earlier this month to accept the deal, says it’s not the right time to sell Canadian Oil Sands given the low price of crude and oil stocks.
Suncor has argued that with oil prices expected to remain low for some time, the status quo is risky for COS shareholders.
Based on Suncor’s most recent closing stock price Thursday, the all-stock bid is worth about $4.5 billion.
Suncor (TSX:SU) took its offer directly to COS shareholders on Oct. 5 after attempts to ink a friendly deal — at a higher price — were rebuffed by Canadian Oil Sands in the spring…
Diesel in France dips below symbolic 1 euro per litre, first since 2009
– canadianbusiness.com
PARIS – The price of diesel in France has slipped below 1 euro a litre for the first time since 2009 — at the height of the financial crisis. The price drop crosses a symbolic barrier that is likely to complicate government efforts to encourage cleaner transportation.
According to figures published late Monday, the average nationwide price of a litre was .99 euros.
Many European consumers prefer diesel cars because they get better mileage and are cheaper to fuel and maintain. In France, the preference is even stronger because of decades-old tax breaks the government is reluctant to lift despite evidence of health risks linked to diesel pollution. Paris Mayor Anne Hidalgo says she wants to “eradicate diesel” by 2020, but French consumers may instead be drawn to the new low prices.
The post Diesel in France dips below symbolic 1 euro per litre, first since 2009 appeared first on Canadian Business – Your Source For Business News.
According to figures published late Monday, the average nationwide price of a litre was .99 euros.
Many European consumers prefer diesel cars because they get better mileage and are cheaper to fuel and maintain. In France, the preference is even stronger because of decades-old tax breaks the government is reluctant to lift despite evidence of health risks linked to diesel pollution. Paris Mayor Anne Hidalgo says she wants to “eradicate diesel” by 2020, but French consumers may instead be drawn to the new low prices.
The post Diesel in France dips below symbolic 1 euro per litre, first since 2009 appeared first on Canadian Business – Your Source For Business News.
Before the Bell: Expect U.S. markets to see solid gains
– theglobeandmail.com
Jennifer Dowty, Chartered Financial Analyst, looks ahead to the market trading day
KaloBios, formerly run by Shkreli, says it is appealing Nasdaq delisting
– canadianbusiness.com
NEW YORK, N.Y. – KaloBios, the biotech company formerly run by Martin Shkreli, says that is appealing a decision by Nasdaq to delist the company from its stock market.
San Francisco-based KaloBios was notified last week that Nasdaq would move to delist the company’s stock because of Shkreli’s arrest and several other issues.
Shkreli was charged with securities fraud earlier this month. KaloBios subsequently fired him as CEO and he resigned from its board.
He became infamous earlier this year after another company he led, Turing Pharmaceuticals Inc., hiked the price of a life-saving drug by 5,000 per cent. He resigned as CEO of Turing following his arrest.
KaloBios Pharmaceuticals Inc. said Tuesday that a hearing on its appeal to Nasdaq will take place in late February.
The post KaloBios, formerly run by Shkreli, says it is appealing Nasdaq delisting appeared first on Canadian Business – Your Source For Business News.
San Francisco-based KaloBios was notified last week that Nasdaq would move to delist the company’s stock because of Shkreli’s arrest and several other issues.
Shkreli was charged with securities fraud earlier this month. KaloBios subsequently fired him as CEO and he resigned from its board.
He became infamous earlier this year after another company he led, Turing Pharmaceuticals Inc., hiked the price of a life-saving drug by 5,000 per cent. He resigned as CEO of Turing following his arrest.
KaloBios Pharmaceuticals Inc. said Tuesday that a hearing on its appeal to Nasdaq will take place in late February.
The post KaloBios, formerly run by Shkreli, says it is appealing Nasdaq delisting appeared first on Canadian Business – Your Source For Business News.


